Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Marc-Olivier Timsit, Laurence Albiges, Arnaud Méjean & Bernard Escudier. (2012) Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives. Expert Review of Anticancer Therapy 12:12, pages 1559-1569.
Read now
Read now
Axel Bex & Tom Powles. (2012) Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when. Expert Review of Anticancer Therapy 12:6, pages 787-797.
Read now
Read now
Articles from other publishers (34)
Jacqueline T. Brown, Yash Jani, Viraj A. Master & Mehmet Asim Bilen. 2023. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma
195
229
.
Alejandro Abello & Patrick A. Kenney. 2020. Renal Cancer. Renal Cancer
411
435
.
Bulent Cetin & Alim Kosar. (2019) Game of thrones: immunotherapy versus molecular targeted therapy in renal cell cancer scenarios. International Urology and Nephrology 51:12, pages 2107-2117.
Crossref
Crossref
Shivashankar Damodaran & E. Jason Abel. 2019. Diagnosis and Surgical Management of Renal Tumors. Diagnosis and Surgical Management of Renal Tumors
247
262
.
Jing Wang, Shuzhi Wu & Tianren Huang. (2018) Expression and role of VEGFA and miR‑381 in portal vein tumor thrombi in patients with hepatocellular carcinoma. Experimental and Therapeutic Medicine.
Crossref
Crossref
Sumi Dey, Henry N. Peabody, Sabrina L. Noyes & Brian R. Lane. (2017) Neoadjuvant Targeted Molecular Therapy Before Renal Surgery. Urologic Clinics of North America 44:2, pages 289-303.
Crossref
Crossref
Earle F. Burgess, Stephen B. Riggs, Brian I. Rini & Derek Raghavan. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
8
.
Leonardo D. Borregales, Mehrad Adibi, Arun Z. Thomas, Christopher G. Wood & Jose A. Karam. (2015) The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma. Therapeutic Advances in Urology 8:2, pages 130-141.
Crossref
Crossref
Michael Froehner, Ulrike Heberling, Stefan Zastrow, Marieta Toma & Manfred P. Wirth. (2016) Growth of a Level III Vena Cava Tumor Thrombus Within 1 Month. Urology 90, pages e1-e2.
Crossref
Crossref
Axel Bex, Thomas Powles & Jose A Karam. (2015) Role of targeted therapy in combination with surgery in renal cell carcinoma. International Journal of Urology 23:1, pages 5-12.
Crossref
Crossref
Shoichiro Mukai, Yuki Kita, Naoko Fujita, Takahiro Akioka, Toyoharu Kamibeppu, Satoru Sugie, Kazutaka Kida, Chie Onizuka, Hiromasa Tukino, Toshio Kamimura, Hironobu Wakeda & Toshiyuki Kamoto. (2014) Presurgical treatment with axitinib in renal cell carcinoma patients with venous extension. International Cancer Conference Journal 4:4, pages 216-220.
Crossref
Crossref
Karin E. Westesson, Joseph C. Klink, John C. Rabets, Amr F. Fergany, Eric A. Klein, Andrew J. Stephenson, Brian I. Rini, Jose Navia & Venkatesh Krishnamurthi. (2014) Surgical Outcomes After Cytoreductive Nephrectomy With Inferior Vena Cava Thrombectomy. Urology 84:6, pages 1414-1419.
Crossref
Crossref
Jose A. Karam, Catherine E. Devine, Diana L. Urbauer, Marisa Lozano, Tapati Maity, Kamran Ahrar, Pheroze Tamboli, Nizar M. Tannir & Christopher G. Wood. (2014) Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma. European Urology 66:5, pages 874-880.
Crossref
Crossref
T. Nakayama, K. Saito, Y. Fujii, S. Abe-Suzuki, Y. Nakanishi, T. Kijima, S. Yoshida, J. Ishioka, Y. Matsuoka, N. Numao, F. Koga & K. Kihara. (2014) Pre-operative Risk Stratification for Cancer-specific Survival in Patients with Renal Cell Carcinoma with Venous Involvement Who Underwent Nephrectomy. Japanese Journal of Clinical Oncology 44:8, pages 756-761.
Crossref
Crossref
Axel Bex & John Haanen. (2013) Do targeted agents offer clinical benefit as presurgical therapy?. World Journal of Urology 32:1, pages 3-8.
Crossref
Crossref
Inga Peters, Michael Winkler, Björn Jüttner, Omke E. Teebken, T. R. Herrmann, Christoph von Klot, Mario Kramer, Angela Reichelt, Mahmoud Abbas, Markus A. Kuczyk & Axel S. Merseburger. (2012) Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case report. World Journal of Urology 32:1, pages 245-248.
Crossref
Crossref
A. Heidenreich, C. Doehn, M. Schenck & G. Jakse. 2014. Uroonkologie. Uroonkologie
347
397
.
A. Heidenreich, C. Doehn, M. Schenck & G. Jakse. 2014. Uroonkologie. Uroonkologie
347
397
.
Shingo Hatakeyama, Takahiro Yoneyama, Itsuto Hamano, Hiromi Murasawa, Takuma Narita, Masaaki Oikawa, Kazuhisa Hagiwara, Daisuke Noro, Toshikazu Tanaka, Yoshimi Tanaka, Yasuhiro Hashimoto, Takuya Koie & Chikara Ohyama. (2013) Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center. BMC Urology 13:1.
Crossref
Crossref
Futoshi Sano, Syusei Fusayasu, Shinji Otake, Hiroyuki Yamanaka, Tomoyuki Tatenuma, Ryoko Sakata, Kazuhide Makiyama, Noboru Nakaigawa, Masahiro Yao & Yoshinobu Kubota. (2013) Early ultrasonographic evaluation of tumor thrombus level during sunitinib therapy for renal cell carcinoma. Journal of Medical Ultrasonics 40:4, pages 463-465.
Crossref
Crossref
Jared M. Whitson, Adam C. Reese & Maxwell V. Meng. (2013) Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus. Urologic Oncology: Seminars and Original Investigations 31:2, pages 259-263.
Crossref
Crossref
Tom Powles & Axel Bex. 2013. Renal Cell Carcinoma. Renal Cell Carcinoma
257
277
.
Patrick A. Kenney & Christopher G. Wood. 2013. Renal Cancer. Renal Cancer
155
177
.
Andres J Schrader, Sandra Steffens, Thomas J Schnoeller, Mark Schrader & Markus A Kuczyk. (2012) Neoadjuvant therapy of renal cell carcinoma: A novel treatment option in the era of targeted therapy?. International Journal of Urology 19:10, pages 903-907.
Crossref
Crossref
Ginil Kumar Pooleri, Tiyadath Balagopalan Nair, Kalavampara V. Sanjeevan & Appu Thomas. (2011) Neo Adjuvant Treatment with Targeted Molecules for Renal Cell Cancer in Current Clinical Practise. Indian Journal of Surgical Oncology 3:2, pages 114-119.
Crossref
Crossref
Patrick A. Kenney & Christopher G. Wood. (2012) Integration of Surgery and Systemic Therapy for Renal Cell Carcinoma. Urologic Clinics of North America 39:2, pages 211-231.
Crossref
Crossref
Hiroki Chiba, Takayuki Hirose, Naohiko Shimoda & Kouichi Kanagawa. (2012) A CASE OF ADVANCED RENAL CELL CARCINOMA WITH INFERIOR VENA CAVA THROMBUS TREATED WITH SUNITINIB AS NEOADJUVANT THERAPY. The Japanese Journal of Urology 103:4, pages 623-626.
Crossref
Crossref
A. Bex, B. K. Kroon & R. de Bruijn. (2012) Is There a Role for Neoadjuvant Targeted Therapy to Downsize Primary Tumors for Organ Sparing Strategies in Renal Cell Carcinoma?. International Journal of Surgical Oncology 2012, pages 1-6.
Crossref
Crossref
Axel Bex, Christian Blank, Wim Meinhardt, Harm van Tinteren, Simon Horenblas & John Haanen. (2011) A Phase II Study of Presurgical Sunitinib in Patients With Metastatic Clear-cell Renal Carcinoma and the Primary Tumor In Situ. Urology 78:4, pages 832-837.
Crossref
Crossref
Axel Bex & Noel Clarke. (2011) Targeted Caval Cytoreduction: Solid Foundations or Shifting Sands?. European Urology 59:6, pages 919-920.
Crossref
Crossref
Nicholas G. Cost, Scott E. DelacroixJr.Jr., Joshua P. Sleeper, Paul J. Smith, Ramy F. Youssef, Brian F. Chapin, Jose A. Karam, Stephen Culp, E. Jason Abel, James Brugarolas, Ganesh V. Raj, Arthur I. Sagalowsky, Christopher G. Wood & Vitaly Margulis. (2011) The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus. European Urology 59:6, pages 912-918.
Crossref
Crossref
M. Staehler, C. Tüllmann, P. Nuhn, N. Haseke & C.G. Stief. (2010) Systemische Therapie beim NierenzellkarzinomSystemic therapy of renal cell carcinoma. Der Urologe 49:12, pages 1543-1552.
Crossref
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:11, pages i-xii.
Crossref
Crossref
Astrid A. M. van der Veldt, Martijn R. Meijerink, Alfons J. M. van den Eertwegh & Epie Boven. (2010) Targeted therapies in renal cell cancer: recent developments in imaging. Targeted Oncology 5:2, pages 95-112.
Crossref
Crossref